Disease correction the iPSC way: Advances in iPSC-based therapy

I. Sancho-Martinez, M. Li, J. C. Izpisua Belmonte

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Pluripotent stem cells possess the capacity for self-renewal and the ability to differentiate into all cell types of the three embryonic germ layers. Accordingly, given their potential use in regenerative medicine, they have long attracted the attention of researchers. Embryonic stem cells (ESCs) represent the model pluripotent stem cell population. However, the use of ESCs in regenerative therapies faces major hurdles-namely, immune rejection and the necessity to use early-stage embryos for ESC isolation.

Original languageEnglish (US)
Pages (from-to)746-749
Number of pages4
JournalClinical Pharmacology and Therapeutics
Issue number5
StatePublished - May 2011
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Disease correction the iPSC way: Advances in iPSC-based therapy'. Together they form a unique fingerprint.

Cite this